noscript

News and Announcements

Anteo Signs Licensing Agreement with Leading Life Science Company

  • Published March 13, 2012 11:41AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

13 March 2012: Anteo Diagnostics Limited (ASX:ADO) is pleased to announce that it has signed a Patent and Technoology License Agreement with eBioesence, a leading US headquartered Life Sciences Company, providing with access to Anteo’s unique Mix&Go technology.

Under the terms of the Agreement, Anteo will supply Mix&Go for the use in the manufacture of biological reagents for all the applicable markets in which the company operates. Anteo will receive an initial upfront payment, fixed revenue for Mix&Go reagent supplied, and a royalty fee paid quarterly based on a percentage of worldwide net sales.

——

To view the full article, please click here.

 

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now